000			04701nam a22003615i 4500
001			76766
003			ES-MaUEC
005			20240611040133.0
007			cr nn 008mamaa
008			130217s2013 ne | s |||| 0|eng d
020			_a9789400757998
024	7		_a10.1007/978-94-007-5799-8 _2doi
040			_aES-MaUEC
050		4	_aRM315 _b.P65 2013 EB
082	0	4	_a610
700	1		_aRitsner, Michael S. _eeditor literario. _986079 _0Local _0http://id.loc.gov/authorities/names/nb2007021481 _1http://viaf.org/viaf/49546172
245	0	0	_aPolypharmacy in Psychiatry Practice _nVolume II, _pUse of Polypharmacy in the "Real World" _cedited by Michael S. Ritsner.
264		1	_aDordrecht, Netherlands _bSpringer International Publishing _c2013
300			_a1 recurso en línea (XVII, 321 páginas) _b2 ilustraciones, 1 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_a1. Antipsychotic polypharmacy for schizophrenia: 'Secret sauce' or 'wild abandon'? -- Antipsychotic polypharmacy in USA -- Antipsychotic polypharmacy in Czech Republic and in Ukraine -- Antipsychotic polypharmacy in residential facilities in Italy: the gap between recommendations and real world practice -- Antipsychotic polypharmacy and associated phenomena in patients with schizophrenia: Rational or irrational? -- Antipsychotic polypharmacy in schizophrenia. How to counteract this common practice? -- Clozapine combinations in treatment-resistant schizophrenia patients -- Metabolic syndrome and antipsychotic polypharmacy -- Evidence based combination therapy for bipolar disorder -- Antidepressant combinationÂ{u3D32}ategies for major depressive disorder -- Herbal remedies and nutraceuticals as augmentation or adjunct for mood and anxiety disorders: evidence for benefit and risk -- Obsessive-compulsive syndromes in schizophrenia: A case for polypharmacy? -- Polypharmacy and potentially inappropriate medication use among elders with dementia -- The role of polypharmacy in bipolar disorder treatment guidelines.
520			_aDespite the large number of psychotropic medications currently available, effective management of mental disorders continues to be a challenging task. Although monotherapy may be desirable, most patients require combinations of two or more psychotropic drugs. Polypharmacy aims to address different aspects of treatment resistance, especially insufficient response of positive and negative symptoms, cognitive disturbances, affective comorbidity, obsessive-compulsive syndromes and side-effects of antipsychotic agents. At the same time, evidence based guidelines in support of polypharmacy, and augmentative strategies are scant. This two-volume collection is the first comprehensive, clinically oriented, reference text on polypharmacy (co-administration of more than one medication) or the use of multiple preparations to treat psychotic, cognitive, mood and anxiety disorders. ThisÂ{u3BEC}lection is divided into four parts. Volume I contains two parts including chapters that serve as an introduction and overview of conceptual issues. Key topics include: rational polypharmacy, receptor binding targets, drug interactions, preclinical and clinical investigations in this field, dosing regimens, multiple medication use in forensic psychiatry, a naturalistic trial, adjunctive strategies, and multiple medication use for the treatment of somatic symptom disorders. Volume II contains two parts that focus on antipsychotic polypharmacy for schizophrenia, and clinical practice in the USA, Czech Republic, Ukraine, and Italy, polypharmacy and associated phenomena, clozapine combinations and the metabolic syndrome. The authors discuss combination therapy for bipolar disorder, major depressive disorder, obsessive-compulsive syndromes in schizophrenia, and potentially inappropriate medication use among elderly patients with dementia. Finally, each volume includes Appendix contains â€Ãnnotated bibliography on polypharmacyâ€{u086E}d â€L̃ist of Psychotropic Medicationsâ€{uE000}
650		7	_9139882 _aPsicofarmacología
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-007-5799-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12823843 _b10-10-17 _c01-10-14
942			_2lcc _cLE
945			_aR-RZ EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11553054 _z06-04-17
988	0	0	_aEBOOK, EBSPRINGER, GOBI_sep2018
988			_aEbook_one2one
998			_aSI _a_alco _a_vill _b10/2018 _cm _dz _ef _feng _gne _h0
999			_c76766 _d76766 _x1